998 search results for “development disease” in the Staff website
-
Stephanus HuijbregtsSocial & Behavioural Sciences
shuijbregts@fsw.leidenuniv.nl | +31 71 527 1723
-
Horst FischerFaculty of Law
h.fischer@law.leidenuniv.nl | +31 71 527 2727
-
Paul van den BroekSocial & Behavioural Sciences
broekpwvanden@fsw.leidenuniv.nl | +31 71 527 2727
-
Jan Michiel OttoFaculty of Law
j.m.otto@law.leidenuniv.nl | +31 71 527 7260
-
Lina van DrunenSocial & Behavioural Sciences
l.van.drunen@fsw.leidenuniv.nl | +31 71 527 2727
-
Catherine WoodFaculty of Humanities
c.m.wood@hum.leidenuniv.nl | +31 71 527 7177
-
Investigating inflammation: new leads for treating atherosclerosis
How do you detect people at high risk of heart attacks and strokes? And how can we improve the treatment of atherosclerosis? These are the questions that keep LACDR researcher Marie Depuydt busy. She is investigating the immune cells that contribute to the worsening of atherosclerosis. ‘It's a challenging…
-
Developing drugs with artificial intelligence
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. PhD defence on 15 February.
-
Eva SchmidtFaculty of Law
e.p.schmidt@umail.leidenuniv.nl | +31 71 527 8070
-
Caroline ArchambaultFaculty of Governance and Global Affairs
c.archambault@luc.leidenuniv.nl | +31 70 800 9963
-
Simone RijksenICLON
s.rijksen@iclon.leidenuniv.nl | 071 5274059
-
Ruben Gonzalez VicenteFaculty of Humanities
r.gonzalez.vicente@hum.leidenuniv.nl | 071 5272727
-
Herman SpainkFaculty of Science
h.p.spaink@biology.leidenuniv.nl | 071 5275055
-
Marnix MedemaFaculty of Science
m.h.medema@biology.leidenuniv.nl | 071 5275672
-
'Migraine requires a gender-specific approach'
Migraine is a brain disease. If it were simple, we would have solved it already'. That is the title of the inaugural lecture delivered by Professor of Neurology Gisela Terwindt on Friday 3 June. In her speech she emphasises the importance of research into the differences between women and men with m…
-
New easy-to-use tuberculosis vaccine patch in development
Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.
-
Greater understanding of specialised cell could prevent strokes
Ilze Bot wants to reduce the prevalence of cardiovascular diseases. Her research focuses on mast cells, which protect us from infections but can also make us ill.
-
Paul GobéeFaculteit Geneeskunde
o.p.gobee@lumc.nl | +31 71 526 6673
-
Fatma Al ManjiFaculty of Science
f.r.a.al.manji@cml.leidenuniv.nl | 071 5272727
-
Timothy NaFaculty of Science
t.c.na@cml.leidenuniv.nl | +31 71 527 2727
-
Xiaoyang ZhongFaculty of Science
x.zhong.2@umail.leidenuniv.nl | +31 71 527 5148
-
Joost VisserFaculty of Science
j.m.w.visser@liacs.leidenuniv.nl | +31 71 527 2727
-
The right diagnosis and faster for women with heart problems
It often takes longer for women with heart problems to get the right diagnosis. In her Annie Romein-Verschoor Lecture, Professor Hester den Ruijter will talk about how hormones influence the heart and the importance of medical research that focuses specifically on women.
-
Nienke BouwSocial & Behavioural Sciences
j.c.bouw@fsw.leidenuniv.nl | +31 71 527 2727
-
Maurijn van der ZeeFaculty of Science
m.van.der.zee@biology.leidenuniv.nl | +31 71 527 4885
-
Michael RichardsonFaculty of Science
m.k.richardson@biology.leidenuniv.nl | +31 71 527 5215
-
Edmund AmannFaculty of Humanities
e.amann@hum.leidenuniv.nl | +31 71 527 1007
-
Biological agents
Biological agents are micro-organisms such as bacteria, parasites, moulds, viruses and their waste products. This category also includes genetically modified variants (GMOs). These agents may form a risk for your health, which is why we apply a number of legal and other guidelines to prevent people…
-
Growth in Conversation: Develop your conversation skills using the principles of GROW
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
Discontinuation of the Development of the Master’s in Environmental Humanities
In recent months, a number of academics, a sounding board group and the relevant directors of education, in collaboration with Campus The Hague, have been working on the development of a new Master’s programme: Environmental Humanities. With this programme, we aimed to offer a new and necessary perspective…
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Echoes of the future
If an echo (or ultrasound) shows that a foetus has a heart or other defect, parents face difficult decisions. Then an idea of their child’s shorter and longer-term future is literally a matter of life and death. Haak will argue in her inaugural lecture that the cohort studies of rare diseases that are…
-
New Year's Reception Faculty of Science
Conference
-
Kees MustersFaculty of Science
musters@cml.leidenuniv.nl | 071 5277461
-
Micha DrukkerFaculty of Science
m.drukker@lacdr.leidenuniv.nl | +31 71 527 6271
-
Martijn van der LiendenFaculty of Science
m.j.c.van.der.lienden@lic.leidenuniv.nl | 071 5272727
-
Berna GürogluSocial & Behavioural Sciences
bguroglu@fsw.leidenuniv.nl | +31 71 527 2727
-
LUMC signs international agreement on developing Advanced Therapy Medicinal Products
Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…
-
How cells determine the fate of proteins (and can we do it too?)
Cells in our bodies are often threatened by errors in our own proteins. The FLOW consortium, comprising scientists from various institutions including Leiden, is poised to meticulously map out for the first time how cells control proteins, correcting or removing faulty ones. This endeavour holds promise…
-
Jonathan PhillipsSocial & Behavioural Sciences
j.p.phillips@fsw.leidenuniv.nl | +31 71 527 2727
-
Ayokunu AdedokunFaculty of Governance and Global Affairs
a.b.adedokun@luc.leidenuniv.nl | +31 70 800 9503
-
Bert KoendersFaculty of Governance and Global Affairs
a.g.koenders@fgga.leidenuniv.nl | 070 8009506
-
Chris RiddellSocial & Behavioural Sciences
c.d.riddell@fsw.leidenuniv.nl | 071 5272727
-
UTQ training- and professional development courses for FGGA lecturers in The Hague (BKO)
Didactics
-
Sophie van RijnSocial & Behavioural Sciences
srijn@fsw.leidenuniv.nl | +31 71 527 2727
-
Employing and Developing Operando Scanning Tunneling Microscopy for Fischer-Tropsch Synthesis
PhD defence
-
Agnieszka KazimierczukAfrican Studies Centre
a.h.kazimierczuk@asc.leidenuniv.nl | +31 71 527 2727
-
Hoko HoriiFaculty of Law
h.horii@law.leidenuniv.nl | +31 71 527 7260
-
Subsidy for development of tools for rheumatic diagnosis
Digital diagnostic tools should improve the diagnostic process of patients with musculoskeletal complaints, so that they can receive the right treatment more quickly.